Feature | Lung Imaging | October 26, 2015

Researchers confirm predictive capabilities of minimally invasive procedure that offers high accuracy for positive and negative diagnosis

University of Missouri, EBUS-TBFNA, lung cancer diagnosis

October 26, 2015 — University of Missouri researchers have developed a new scoring system for a common lung cancer diagnostic test that may help physicians better understand the risk for malignancy when evaluating patients.

Endobronchial ultrasound-guided transbronchial fine-needle aspiration, or EBUS-TBFNA, is a minimally invasive procedure often used for the initial diagnosis of many lung cancers. The test uses a thin, flexible scope that passes through the mouth and into the lungs to remove a small piece of tissue for evaluation. The test is commonly used because it can provide a rapid cancer diagnosis without the need for an invasive open procedure.

“The EBUS-TBFNA procedure is a diagnostic tool for lung cancer that yields proven results,” said Lester Layfield, M.D., professor and chair of the Department of Pathology and Anatomical Sciences at the MU School of Medicine and lead author of the study. “The test categorizes the results as ‘benign,’ ‘non-diagnostic,’ ‘atypical,’ ‘suspicious for malignancy’ or ‘malignant.’ Our goal with this study was to understand the risk of cancer associated with each category.”

Layfield’s research team evaluated information from 136 patients who received a diagnosis following the EBUS-TBFNA procedure. The same patients then had an open surgical procedure to confirm whether the tissue was cancerous or benign.

Layfield’s research team found that the EBUS-TBFNA tool provided an accurate positive diagnosis of lung cancer 84 percent of the time and an accurate negative diagnosis of lung cancer 68 percent of the time. The study also provided the research team with an estimation of malignancy risks for each category, which in the future could help doctors offer patients enhanced care and counseling, Layfield said.

The study, “Malignancy Risk Associated with the EBUS-FNA Diagnostic Categories Nondiagnostic, Benign, Atypical, Suspicious for Malignancy, and Malignant for Mediastinal Lymph Node Aspirate Specimens,” recently was published in the Journal of the American Society of Cytopathology.

For more information: www.jascyto.org

Related Content

Feature | Coronavirus (COVID-19) | By Avielle Siegel, Paul J. Chang, David M. Paushter, et al.

A 26-year-old man with history of diabetes and hypertension presented with 7 days of fever, chills, nausea, intractable ...

Time January 19, 2022
arrow
News | Magnetic Resonance Imaging (MRI)

January 18, 2022 — Magnetic resonance imaging (MRI) is a powerful medical tool that provides detailed images of ...

Time January 18, 2022
arrow
News | Lung Imaging

January 17, 2022 — A recent, substantial decline in lung cancer deaths is associated with earlier diagnosis of lung ...

Time January 17, 2022
arrow
News | Pediatric Imaging

December 15, 2021 — Diagnosis of community acquired pneumonia in children usually involves X-rays, despite ...

Time December 15, 2021
arrow
News | Lung Imaging

December 10, 2021 — According to an article in ARRS’ American Journal of Roentgenology (AJR), MRI—with or without FDG ...

Time December 10, 2021
arrow
News | Radiation Therapy

December 6, 2021 — RefleXion Medical Inc., a therapeutic oncology company, announced that the U.S. Food and Drug ...

Time December 06, 2021
arrow
News | Artificial Intelligence

November 28, 2021 — Riverain Technologies, a leader in artificial intelligence (AI) for early, efficient detection of ...

Time November 28, 2021
arrow
News | Lung Imaging

November 23, 2021 — Median Technologies announces new outstanding performance of its lung cancer screening (LCS) CADx1 ...

Time November 23, 2021
arrow
News | Artificial Intelligence

November 22, 2021 — Sirona Medical, a software company founded on a deep understanding of both the practice and business ...

Time November 22, 2021
arrow
News | Coronavirus (COVID-19)

November 22, 2021 — Lung autopsy and plasma samples from people who died of COVID-19 have provided a clearer picture of ...

Time November 22, 2021
arrow
Subscribe Now